Related Experiment Video

Updated: May 16, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis

Marcus W Koch1, Luanne M Metz, Olga Kovalchuk

  • 1Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada. mwkoch@ucalgary.ca

Trends in Molecular Medicine
|November 17, 2012
PubMed

Insights

Epigenetic changes, including DNA methylation and miRNA, are increasingly recognized as crucial factors in multiple sclerosis (MS) development and progression. Research is exploring their potential as diagnostic and prognostic biomarkers for MS.

Area of Science:

  • Neuroimmunology
  • Epigenetics
  • Genomics

Background:

  • Multiple sclerosis (MS) risk involves genetic and environmental factors.
  • Epigenetic modifications, which alter gene expression without changing DNA sequence, are emerging as key players in MS pathogenesis.
  • Understanding these epigenetic factors is crucial for advancing MS research.

Purpose of the Study:

  • To review recent studies on epigenetic changes and microRNAs (miRNAs) in multiple sclerosis.
  • To evaluate the potential of epigenetic markers as biomarkers for MS diagnosis and prognosis.
  • To discuss the clinical implications and future research directions for epigenetics in MS.

Main Methods:

  • Literature review of recent studies on epigenetics and MS.
  • Analysis of research investigating DNA methylation, histone modification, and miRNA-associated silencing in MS.
  • Synthesis of findings related to biomarker potential and clinical applications.

Main Results:

  • Epigenetic mechanisms like DNA methylation and miRNA dysregulation are implicated in MS.
  • These epigenetic factors show promise as biomarkers for MS diagnosis, disease course prediction, and treatment response.
  • Current research highlights the need for further investigation into their clinical utility.

Conclusions:

  • Epigenetic modifications represent a significant area of research in multiple sclerosis.
  • miRNAs and other epigenetic markers hold potential for improving MS diagnostics and personalized treatment strategies.
  • Future studies should focus on validating these biomarkers for clinical practice.

More Related Videos

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis05:55

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

Hypoxia Alters miRNAs Levels Involved in Non-Mendelian Inheritance of Autism Spectrum Disorder in Mice09:13

Hypoxia Alters miRNAs Levels Involved in Non-Mendelian Inheritance of Autism Spectrum Disorder in Mice

Published on: July 11, 2025

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...